Diabetes does not affect outcome of symptomatic carotid stenosis treated with endovascular techniques

Aida Lago1, Vera Parkhutik, Jose Ignacio Tembl

  • 1Department of Neurology, Hospital Universitari la Fe, Valencia, Spain. alagom @ meditex.es

European Neurology
|February 23, 2013
PubMed

Insights

Diabetes does not increase risks for patients undergoing carotid angioplasty and stenting (CAS). This study found similar outcomes for diabetic and non-diabetic patients treated with CAS for carotid stenosis.

Area of Science:

  • Cardiovascular Medicine
  • Endovascular Surgery
  • Diabetology

Background:

  • The impact of diabetes on carotid revascularization outcomes, particularly carotid angioplasty and stenting (CAS), remains debated.
  • Limited data exists on the safety and efficacy of CAS in diabetic patients with carotid stenosis.

Purpose of the Study:

  • To investigate whether diabetes mellitus is a risk factor for adverse outcomes in patients with symptomatic carotid stenosis undergoing CAS.
  • To compare the 30-day and long-term morbidity, mortality, and restenosis rates between diabetic and non-diabetic patients treated with CAS.

Main Methods:

  • A comparative study of 318 patients (116 diabetics) with symptomatic carotid stenosis treated with endovascular techniques.
  • Analysis of 30-day and long-term outcomes, including stroke, ischemic cardiopathy, death, and restenosis rates (≥50%).
  • Follow-up was conducted for a median of 56 months.

Main Results:

  • No significant differences in 30-day (4% vs. 5.2%) or long-term (26.4% vs. 34.3%) stroke and mortality rates between non-diabetic and diabetic patients.
  • Diabetic patients showed a higher incidence of death due to myocardial infarction (44% vs. 17.5%, p=0.04).
  • Restenosis rates (≥50%) were similar between groups (5.9% vs. 7.4%).

Conclusions:

  • Carotid angioplasty and stenting (CAS) is an effective and safe endovascular treatment for diabetic patients with symptomatic carotid stenosis.
  • Diabetes mellitus did not emerge as an independent risk factor for increased complications following CAS in this patient cohort.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...